These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34817646)

  • 1. Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy.
    Lawin D; Lawrenz T; Radke K; Stellbrink C
    Clin Res Cardiol; 2022 Feb; 111(2):207-217. PubMed ID: 34817646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.
    Aguiar Rosa S; Fiarresga A; Galrinho A; Cacela D; Ramos R; de Sousa L; Gonçalves A; Bernardes L; Patrício L; Branco LM; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):473-480. PubMed ID: 31495717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol-induced right bundle branch block is associated with a benign outcome in HOCM after alcohol septum ablation (ASA).
    Lawin D; Lawrenz T; Radke K; Wolff A; Stellbrink C
    Clin Res Cardiol; 2022 Feb; 111(2):175-185. PubMed ID: 33772362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Lawin D; Lawrenz T; Marx K; Danielsmeier NB; Poudel MR; Stellbrink C
    Heart; 2022 Sep; 108(20):1623-1628. PubMed ID: 35697495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Lawin D; Stellbrink C; Stellbrink E; Buck B; Poudel MR; Tego A; Marx K; Lawrenz T
    Heart; 2023 Nov; 109(23):1778-1784. PubMed ID: 37460195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
    [No Abstract]   [Full Text] [Related]  

  • 7. Mid-term outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in patients with sigmoid versus neutral ventricular septum.
    Veselka J; Tomasov P; Zemánek D
    J Invasive Cardiol; 2012 Dec; 24(12):636-40. PubMed ID: 23220977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy and safety of coil embolization of septal branch in the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu H; Wu Q; Tan HW; Pang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1044-1048. PubMed ID: 29325364
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effects of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy].
    Li PJ; Sun JJ; Chen ML; Yu XP; Zhao H; Gao YC; Zhang XL; Jiang TY; He JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Apr; 50(4):369-374. PubMed ID: 35399033
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly.
    Liebregts M; Steggerda RC; Vriesendorp PA; van Velzen H; Schinkel AF; Willems R; van Cleemput J; van den Berg MP; Michels M; ten Berg JM
    JACC Cardiovasc Interv; 2016 Mar; 9(5):463-9. PubMed ID: 26965935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Septal Thickness on the Clinical Outcome After Alcohol Septal Alation in Hypertrophic Cardiomyopathy.
    Jensen MK; Jacobsson L; Almaas V; van Buuren F; Hansen PR; Hansen TF; Aakhus S; Eriksson MJ; Bundgaard H; Faber L
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27217377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
    Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
    Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
    Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
    Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
    Poon SS; Field M; Gupta D; Cameron D
    Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender Disparities in Clinical Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in the Chinese Han Population: A Cohort Study.
    Wang Y; Zhao HW; Wang CF; Meng QK; Cui CS; Zhang XJ; Zhu Y; Fan CY; Luo DF; Chen BJ; Luan B; Hou AJ
    Heart Lung Circ; 2020 Dec; 29(12):1856-1864. PubMed ID: 32611501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.
    Liebregts M; Faber L; Jensen MK; Vriesendorp PA; Januska J; Krejci J; Hansen PR; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg JM; Veselka J
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1134-1143. PubMed ID: 28595881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy through non-left anterior descending septal perforators.
    Imori Y; Takano H; Kitamura M; Aoyama R; Sangen H; Kenta O; Matsuda J; Kubota Y; Tokita Y; Yamamoto T; Asai K; Takayama M; Shimizu W
    Heart Vessels; 2020 May; 35(5):647-654. PubMed ID: 31641886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic phase improvements in electrocardiographic and echocardiographic manifestations of left ventricular hypertrophy after alcohol septal ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
    Matsuda J; Kitamura M; Takayama M; Imori Y; Shibuya J; Kubota Y; Sangen H; Nakamura S; Takano H; Asai K; Shimizu W
    Heart Vessels; 2018 Mar; 33(3):246-254. PubMed ID: 28965135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Vermaete I; Dujardin K; Stammen F
    Acta Cardiol; 2020 Oct; 75(6):483-491. PubMed ID: 31204591
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of left ventricular mass, left atrial size, and N-terminal pro-B-type natriuretic peptide level following alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Dąbrowski M; Kukuła K; Kłopotowski M; Bekta P; Śpiewak M; Mazurkiewicz Ł; Tyczyński P; Orczykowski M; Parma R; Witkowski A
    Kardiol Pol; 2019; 77(2):181-189. PubMed ID: 30566209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.